Healthy Skepticism Library item: 19092

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Ladd EC, Mahoney DF, Emani S.
'Under the radar': nurse practitioner prescribers and pharmaceutical industry promotions.
Am J Manag Care 2010 1; 16:(12):e358-62
http://www.ajmc.com/issue/managed-care/2010/2010-12-vol16-n12/AJMC_10decLadd_WebX_e358to62

Abstract:

OBJECTIVE: To assess nurse practitioners’ interactions with pharmaceutical industry promotional activities and their perception of information reliability and self-reported prescribing behaviors.

STUDY DESIGN: Self-administered online survey.

METHODS: A nationally randomized sample of nurse practitioner prescribers was surveyed. Eligibility criteria included current clinical practice and licensure to prescribe medications in their state of practice.

RESULTS: A total of 263 responses were analyzed. Almost all respondents (96%) reported regular contact with pharmaceutical sales representatives, and most (71%) reported receiving information on new drugs directly from pharmaceutical sales representatives some or most of the time. A large portion (66%) dispensed drug samples regularly to their patients, and 73% believed that samples were somewhat or very helpful in learning about new drugs. Eighty-one percent of respondents thought that it was ethically acceptable to give out samples to anyone, and 90% believed that it was acceptable to attend lunch and dinner events sponsored by the pharmaceutical industry. Almost half (48%) stated that they were more likely to prescribe a drug that was highlighted during a lunch or dinner event. Most respondents stated that it was ethically acceptable for speakers to be paid by industry.

CONCLUSIONS: Nurse practitioner prescribers had extensive contact with pharmaceutical industry promotional activities such as pharmaceutical representative contact, receipt of drug samples, and regular attendance at industry-sponsored meal events and continuing education programs. They reported that industry interface with nurse practitioner prescribers in the form of sponsored meals, education events, and paid speakers was ethically acceptable.